Zacks Investment Research
31 Dec 2025, 16:01 UTC · 37w ago
Verdict
Source says Buy. We score PATH +0.90 across three claims.
Score confirms the headline.
Buy
Rating stated in the headline
+0.90strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Slide Insurance Holdings (SLDE) saw its Zacks Consensus Estimate for current year earnings increase by 21% over the last 60 days.
More positive than 77% of claims this week
Ulta Beauty (ULTA) experienced a 4.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Continue reading
5 related stories
More positive than 94% of ticker scores this week
Scored by the NIS engine · methodology.
More positive than 51% of claims this week
UiPath (PATH) witnessed a 3.1% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
More positive than 42% of claims this week
Which stocks this story touches
More positive than 94% of ticker scores this week
The company has a Zacks Rank #1, increasing earnings estimates, and significant share price gains over the last three months.
More positive than 94% of ticker scores this week
The company has a Zacks Rank #1, a 21% increase in earnings estimates, and strong recent share price performance.
More positive than 94% of ticker scores this week
The company has a Zacks Rank #1 (Strong Buy), increasing earnings estimates, and strong share price momentum.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−20.6%
Price is moving against the score
$13.25 vs $16.68 close before publication (Dec 30) · not market-adjusted
PATH chart →